Showing results (141-150 of 252) with videos related to
Sort By:
Pageof 26
Blood Neoplasia|June 3, 2026
CMML is in the eye of the be-WHO-lder: interrogating the newly proposed entity of oligomonocytic CMML: MDS or CMML?Rami S Komrokji, Zena Komrokji, Najla H Al Ali, et al.Leukemia Research|July 30, 2019
Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC)Seongseok Yun, Rohit Sharma, Onyee Chan, et al.Leukemia & Lymphoma|February 25, 2020
Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated RUNX1 versus acute myeloid leukemia with myelodysplasia-related changes with mutated RUNX1Lynh Nguyen, Xiaohui Zhang, Evans Roberts, et al.American Journal of Hematology|October 24, 2012
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromesRami S Komrokji, Maria Corrales-Yepez, Mohamed A Kharfan-Dabaja, et al.Leukemia Research|December 21, 2022
Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patientsSomedeb Ball, Luis E Aguirre, Akriti G Jain, et al.American Journal of Hematology|September 14, 2023
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemiaParth C Patel, Somedeb Ball, Akriti G Jain, et al.Blood|January 29, 2021
CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1Roger Belizaire, Sebastian H J Koochaki, Namrata D Udeshi, et al.American Journal of Hematology|August 19, 2015
Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better?Amer M Zeidan, Mikkael A Sekeres, Xiao-Feng Wang, et al.Hemasphere|November 15, 2019
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNetRaphael Itzykson, Pierre Fenaux, David Bowen, et al.Clinical Lymphoma, Myeloma & Leukemia|September 20, 2020
Classical Hodgkin Lymphoma: Clinicopathologic Features, Prognostic Factors, and Outcomes From a 28-Year Single Institutional ExperienceAshley Rose, Ariel Grajales-Cruz, Alex Lim, et al.Pageof 26